Veru Inc. (VERU) stock
VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
$2.14+0.06 (+2.88%)
Close on Nov 17, 2026Market cap $36.49MP/E –Yield –
Veru total assets
Total assets on the balance sheet at the end of each period.
Veru's total assets was $37.03M at Jun 30, 2026. For fiscal 2025 it was $29.84M, down 50.6% from the year before. Over ten years it grew -2.3% a year on average. The highest annual figure on record is $178.15M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $29.84M | -50.6% |
| FY2024 | Sep 30, 2024 | $60.42M | +20.8% |
| FY2023 | Sep 30, 2023 | $50.02M | -63.0% |
| FY2022 | Sep 30, 2022 | $135.36M | -24.0% |
| FY2021 | Sep 30, 2021 | $178.15M | +245.6% |
| FY2020 | Sep 30, 2020 | $51.54M | -3.9% |
| FY2019 | Sep 30, 2019 | $53.63M | +10.7% |
| FY2018 | Sep 30, 2018 | $48.45M | -12.4% |
| FY2017 | Sep 30, 2017 | $55.34M | +43.3% |
| FY2016 | Sep 30, 2016 | $38.62M | +3.1% |
| FY2015 | Sep 30, 2015 | $37.47M | +18.3% |
| FY2014 | Sep 30, 2014 | $31.67M | -9.9% |
| FY2013 | Sep 30, 2013 | $35.17M | +15.5% |
| FY2012 | Sep 30, 2012 | $30.45M | +56.6% |
| FY2011 | Sep 30, 2011 | $19.44M | +5.9% |
| FY2010 | Sep 30, 2010 | $18.37M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $37.03M | +35.5% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $43.08M | +31.9% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $47.57M | +19.4% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $29.84M | -50.6% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $27.33M | -57.7% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $32.67M | -54.5% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $39.83M | -50.6% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $60.42M | +20.8% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $64.63M | +7.4% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $71.80M | +2.1% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $80.57M | -20.4% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $50.02M | -63.0% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $60.20M | -62.5% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $70.34M | -59.3% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $101.27M | -41.2% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $135.36M | -24.0% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $160.58M | -10.8% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $172.83M | -4.6% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $172.16M | +136.5% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $178.15M | +245.6% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $180.07M | +176.2% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $181.15M | +224.2% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $72.79M | +33.5% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $51.54M | -3.9% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $65.19M | +21.1% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $55.88M | +9.5% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $54.54M | +4.2% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $53.63M | +10.7% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $53.84M | +0.7% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $51.01M | -12.3% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $52.33M | +2.5% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $48.45M | -12.4% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $53.47M | -6.9% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $58.20M | +1.8% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $51.05M | -15.7% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $55.34M | +43.3% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $57.43M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $57.18M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $60.56M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $38.62M | – |
See a number that looks wrong?